ResearcherCzech Academy of Sciences, Institute of Macromolecular ChemistryActive in the last 2 years
Taras Vasylyshyn
Matched on ORCID iD 0000-0002-3762-5624; OpenAlex author ID A5052771192. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2024: 2 papers
Papers 2
- Temoporfin-Conjugated PEGylated Poly(N,N-dimethylacrylamide)-Coated Upconversion Colloid for NIR-Induced Photodynamic Therapy of Pancreatic Cancer. Co-author DOI 10.1021/acs.biomac.4c00317↗
- Intraperitoneal versus intravenous administration of Flamma®-conjugated PEG-alendronate-coated upconversion nanoparticles in a mouse pancreatic cancer model. Co-author DOI 10.1039/d4na00764f↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Oleksandr Shapoval · 2 shared papers, 2024 · strength 0.45
- Paper Intraperitoneal versus intravenous administration of Flamma®-conjugated PEG-alendronate-coated upconversion nanoparticl… DOI 10.1039/d4na00764f↗
- Paper Temoporfin-Conjugated PEGylated Poly(N,N-dimethylacrylamide)-Coated Upconversion Colloid for NIR-Induced Photodynamic T… DOI 10.1021/acs.biomac.4c00317↗
- David Větvička · 2 shared papers, 2024 · strength 0.45
- Paper Intraperitoneal versus intravenous administration of Flamma®-conjugated PEG-alendronate-coated upconversion nanoparticl… DOI 10.1039/d4na00764f↗
- Paper Temoporfin-Conjugated PEGylated Poly(N,N-dimethylacrylamide)-Coated Upconversion Colloid for NIR-Induced Photodynamic T… DOI 10.1021/acs.biomac.4c00317↗
- Daniel Horák · 2 shared papers, 2024 · strength 0.45
- Paper Intraperitoneal versus intravenous administration of Flamma®-conjugated PEG-alendronate-coated upconversion nanoparticl… DOI 10.1039/d4na00764f↗
- Paper Temoporfin-Conjugated PEGylated Poly(N,N-dimethylacrylamide)-Coated Upconversion Colloid for NIR-Induced Photodynamic T… DOI 10.1021/acs.biomac.4c00317↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.